Stock Scorecard



Stock Summary for Milestone Scientific Inc (MLSS) - $0.40 as of 5/6/2026 3:32:22 AM EST

Total Score

8 out of 30

Safety Score

3 out of 100

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for MLSS

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MLSS

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MLSS

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MLSS

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MLSS (3 out of 100)

Stock Price Rating (Max of 10) 1
Historical Stock Price Rating (Max of 10) 1
Stock Price Trend (Max of 10) 2
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 0
Analyst Strong Buy Ratings (Max of 5) 0
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 0
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) -10

Latest News for for MLSS

Milestone Scientific will discuss Q1 results and business update May 14 5/7/2026 8:40:00 PM
Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call 5/7/2026 7:40:00 PM
Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption 5/7/2026 12:39:00 PM
Doctors in 7 states begin epidural procedures with CompuFlo 5/7/2026 12:39:00 PM
Milestone Scientific Inc. Files Form 8-K Announcing Change in Auditor – May 2026 SEC Filing 5/7/2026 9:39:00 AM
Milestone Scientific appoints Grassi & Co. as new auditor, dismisses CBIZ CPAs 5/6/2026 9:09:00 PM
Milestone Scientific approves stock option repricing and new performance-based awards 5/6/2026 9:09:00 PM
Auditor switch at Milestone Scientific (NYSE: MLSS) after going concern note 5/6/2026 9:09:00 PM
Milestone Scientific (NYSE: MLSS) reprices options and grants 11.2M performance RSUs 5/6/2026 9:09:00 PM
[10-K/A] MILESTONE SCIENTIFIC INC. Amends Annual Report 5/5/2026 8:08:00 PM

Financial Details for MLSS

Company Overview

Ticker MLSS
Company Name Milestone Scientific Inc
Country N/A
Description Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States, China, and internationally. The company is headquartered in Livingston, New Jersey.
Sector Name HEALTHCARE
Industry Name MEDICAL INSTRUMENTS & SUPPLIES
Most Recent Quarter 12/31/2025
Next Earnings Date 5/21/2026

Stock Price History

Last Day Price 0.40
Price 4 Years Ago 0.48
Last Day Price Updated 5/6/2026 3:32:22 AM EST
Last Day Volume 911,400
Average Daily Volume 4,091,166
52-Week High 1.05
52-Week Low 0.22
Last Price to 52 Week Low 81.82%

Valuation Measures

Trailing PE N/A
Industry PE 236.87
Sector PE 81.50
5-Year Average PE -5.08
Free Cash Flow Ratio 40.00
Industry Free Cash Flow Ratio 27.14
Sector Free Cash Flow Ratio 24.59
Current Ratio Most Recent Quarter 1.81
Total Cash Per Share 0.01
Book Value Per Share Most Recent Quarter 0.04
Price to Book Ratio 10.63
Industry Price to Book Ratio 3.40
Sector Price to Book Ratio 9.97
Price to Sales Ratio Twelve Trailing Months 3.50
Industry Price to Sales Ratio Twelve Trailing Months 4.68
Sector Price to Sales Ratio Twelve Trailing Months 4.70
Analyst Buy Ratings N/A
Analyst Strong Buy Ratings N/A

Share Statistics

Total Shares Outstanding 88,416,000
Market Capitalization 35,366,400
Institutional Ownership N/A

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.74%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -21.40%
Reported EPS 12 Trailing Months -0.07
Reported EPS Past Year -0.01
Reported EPS Prior Year -0.07
Net Income Twelve Trailing Months -5,722,216
Net Income Past Year -5,722,216
Net Income Prior Year -4,713,597
Quarterly Revenue Growth YOY 2.20%
5-Year Revenue Growth 10.54%
Operating Margin Twelve Trailing Months -52.50%

Balance Sheet

Total Cash Most Recent Quarter 1,112,642
Total Cash Past Year 1,112,642
Total Cash Prior Year 3,258,058
Net Cash Position Most Recent Quarter 312,642
Net Cash Position Past Year 312,642
Long Term Debt Past Year 800,000
Long Term Debt Prior Year 0
Total Debt Most Recent Quarter 800,000
Equity to Debt Ratio Past Year 0.78
Equity to Debt Ratio Most Recent Quarter 0.78
Total Stockholder Equity Past Year 2,812,623
Total Stockholder Equity Prior Year 5,832,700
Total Stockholder Equity Most Recent Quarter 2,812,623

Free Cash Flow

Free Cash Flow Twelve Trailing Months -2,940,643
Free Cash Flow Per Share Twelve Trailing Months -0.03
Free Cash Flow Past Year -2,931,751
Free Cash Flow Prior Year -2,930,000

Options

Put/Call Ratio 0.00
Has Options False
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.97
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 0.76

System

Modified 5/7/2026 3:49:08 AM EST